About Cardiovascular Systems, Inc. (CSII) — Dividend Analysis 2026
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.
Is CSII a good dividend investment in 2026?
CSII offers a 10.00% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
CSII DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your CSII portfolio grows to $21.1K vs $16.1K without reinvestment. This is the compound interest effect in action.
CSII dividend growth history & forecast
CSII has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 10.00%.
Company generates negative FCF ($-28M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 CSII Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CSII.
Gross yield
10.00%
Tax rate
15.00%
After-tax yield
8.50%
Real yield (−CPI)
5.70%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
10.00%
7.20%
$1,000 / yr
🇺🇸 US Taxable (15%) ✓
15%
8.50%
5.70%
$850 / yr
🇺🇸 US Taxable (20%)
20%
8.00%
5.20%
$800 / yr
🇬🇧 UK ISA
0%
10.00%
7.20%
$1,000 / yr
🇬🇧 UK Taxable
8.75%
9.13%
6.33%
$913 / yr
🇨🇦 TFSA
0%
10.00%
7.20%
$1,000 / yr
🇨🇦 CA Taxable
25%
7.50%
4.70%
$750 / yr
🇦🇺 Super (pension)
15%
8.50%
5.70%
$850 / yr
🇦🇺 AU Taxable
30%
7.00%
4.20%
$700 / yr
🇩🇪 DE Taxable
26.375%
7.36%
4.56%
$736 / yr
🇫🇷 FR Taxable
30%
7.00%
4.20%
$700 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CSII Income Goal & Break-Even
Dividend Break-Even
12yr
Years for dividends to fully repay your CSII investment of $20.00/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$13.8K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$11.3K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in CSII for:
Shares needed
14,118
Capital required
$282,360
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CSII Dividend Payment Schedule
CSII pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 CSII vs Healthcare Benchmarks
How CSII compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+7.20% vs sectorBetter
CSII
10.00%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
CSII
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
CSII
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CSII sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CSII Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
Insider
Title
Type
Date
Shares
Price
Total Value
Paulsen Erik
director
D-Return
2023-04-27
700
$20.00
$14.0K
Paulsen Erik
director
D-Return
2023-04-27
20,627
—
—
Points Jeffrey S.
officer: Chief Financial Officer
D-Return
2023-04-27
138,957
$20.00
$2.78M
Points Jeffrey S.
officer: Chief Financial Officer
D-Return
2023-04-27
34,051
$20.00
$681.0K
Rempe Stephen J.
officer: Chief Human Resources Officer
D-Return
2023-04-27
75,659
$20.00
$1.51M
Rempe Stephen J.
officer: Chief Human Resources Officer
D-Return
2023-04-27
8,561
$20.00
$171.2K
Sedo Sandra
officer: Chief Compliance Officer
D-Return
2023-04-27
81,881
$20.00
$1.64M
Sedo Sandra
officer: Chief Compliance Officer
D-Return
2023-04-27
32,503
$20.00
$650.1K
Aronson Martha Goldberg
director
D-Return
2023-04-27
29,816
—
—
Aronson Martha Goldberg
director
D-Return
2023-04-27
12,411
$20.00
$248.2K
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
🎯
Analyst Price Target
Wall Street consensus
Current Price
$20.00
Analyst Target
$17.50
Upside / Downside
-12.5%
Range
$15.00 – $20.00
💡 If CSII reaches the analyst target of $17.50, investors buying today at $20.00 would see an effective yield of 11.43% on shares purchased at target price — vs 10.00% at current price.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
🔬
Financial Health Scores
Altman Z-Score
6.12
✅ Safe Zone — low bankruptcy risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
5/9
⚠️ Moderate fundamentals
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
🌍
Geographic Revenue Breakdown
Where CSII earns its money
UNITED STATES100%
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CSII dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →